Current regulatory (draft) guidance on chiral medicinal products: Canada, EEC, Japan, United States
The rapid development of stereospecific analytical, synthetic, and preparative methods has profoundly changed the prospects for development and application of chiral medicinal products. This has induced regulatory agencies, e.g., in Canada, the EEC, Japan, and the United States, to prepare guidance...
Saved in:
Published in | Chirality (New York, N.Y.) Vol. 6; no. 2; p. 72 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
1994
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!